Jerika A.

Jerika A. has extensive experience in the field of clinical research and operations. Jerika is currently working as a Project Director at Proxima Clinical Research, Inc. Prior to this, they held the position of Senior Director of Clinical Operations at MEDIcept Inc., where they worked from March 2022 to 2023. Before that, they served as the Director of Clinical Operations at both MEDIcept Inc. and ACMP Clinical and Regulatory Consulting LLC, with their tenure at MEDIcept Inc. lasting from January 2021 to March 2022, and at ACMP Clinical and Regulatory Consulting LLC from October 2019 to December 2020. Jerika also worked as a Senior Global Project Lead at Parexel from October 2019 to January 2021, and as a Director of Clinical Operations at Celerion from August 2018 to October 2019. Jerika'searlier experience includes roles such as Global Project Lead at PAREXEL from June 2013 to August 2018, Clinical Operations Lead at TKL Research from January 2012 to May 2013, Clinical Research Consultant at North American Clinical Trials Network (NACTN) from April 2011 to January 2012, Clinical Trial Manager at PRA International from October 2008 to April 2011, and Clinical Project Manager at North American Clinical Trials Network from January 2007 to October 2008. Overall, Jerika A. has a wealth of experience in clinical research and operations, with a proven track record in leadership roles.

Jerika A. completed their Bachelor of Science (BS) degree in Pharmacy at Rutgers University - Newark from 2001 to 2003. Jerika then pursued a Doctor of Pharmacy - PharmD degree at Rutgers New Jersey Medical School from 2003 to 2006. In terms of additional certifications, Jerika obtained various certifications from the CITI Program, including Biomedical (Biomed) Comprehensive, Conflicts of Interest, Biomedical Responsible Conduct of Research, GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus), Humanities Responsible Conduct of Research, and Researchers - Information Privacy and Security (IPS) in the year 2023. In 2022, they acquired certifications such as GCP for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus), the Member of the Association of Clinical Research Professionals, the CDER SBIA from the FDA, GCP for Clinical Trials with Investigational Drugs and Medical Devices (U.S. FDA Focus) Course, and the Health Privacy (HIPAA) from the CITI Program. Jerika has also been recognized as a Clinical Research Professional, although no specific institution or year is provided for this recognition.